| Product NDC: | 66213-200 |
| Proprietary Name: | Compazine |
| Non Proprietary Name: | Prochlorperazine |
| Active Ingredient(s): | 25 mg/1 & nbsp; Prochlorperazine |
| Administration Route(s): | RECTAL |
| Dosage Form(s): | SUPPOSITORY |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 66213-200 |
| Labeler Name: | PBM Pharmaceuticals, Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040246 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130701 |
| Package NDC: | 66213-200-12 |
| Package Description: | 25 SUPPOSITORY in 1 PACKET (66213-200-12) |
| NDC Code | 66213-200-12 |
| Proprietary Name | Compazine |
| Package Description | 25 SUPPOSITORY in 1 PACKET (66213-200-12) |
| Product NDC | 66213-200 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Prochlorperazine |
| Dosage Form Name | SUPPOSITORY |
| Route Name | RECTAL |
| Start Marketing Date | 20130701 |
| Marketing Category Name | ANDA |
| Labeler Name | PBM Pharmaceuticals, Inc |
| Substance Name | PROCHLORPERAZINE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Phenothiazine [EPC],Phenothiazines [Chemical/Ingredient] |